Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...

Billion CAGR (2024-2030): 3.65% Market Segmentation: Reagent Type, Technology, Application, End-users, and Geography ...

The Food and Drug Administration is suspending a quality control program for testing of fluid milk and other dairy products ...

The voices, values and lived experience of people living with dementia - and their families - must shape the path forward for ...

The European Medicines Agency (EMA), after initial rejection based on an unfavourable risk-benefit balance, recently recommended approval of lecanemab for treating people with mild cognitive ...

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...